Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Are triple-negative tumours and basal-like breast cancer synonymous?
Rakha EA, Tan DS, Foulkes WD, Ellis IO, Tutt A, Nielsen TO, Reis-Filho JS
Breast Cancer Res 2007, 9:404; author reply 405
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
Darb-Esfahani S, Loibl S, Müller BM, Roller M, Denkert C, Komor M, Schlüns K, Blohmer JU, Budczies J, Gerber B, Noske A, du Bois A, Weichert W, Jackisch C, Dietel M, Richter K, Kaufmann M, von Minckwitz G
Breast Cancer Research 2009, 11:R69 (16 September 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.

Review   
Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer
Miles DW
Breast Cancer Research 2009, 11:208 (28 August 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.


Research    
Does vimentin help to delineate the so-called 'basal type breast cancer'?
Kusinska RU, Kordek R, Pluciennik E, Bednarek AK, Piekarski JH, Potemski P
Journal of Experimental & Clinical Cancer Research 2009, 28:118 (20 August 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.